Form 4 Tracker
Samarth Kulkarni

Director; Director, Chief Executive Officer · 9 filings · Latest: Oct 13, 2026

Black Diamond Therapeutics, Inc.
Centessa Pharmaceuticals plc
CRISPR Therapeutics AG
Oruka Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CRSP
Samarth KulkarniDirector, Chief Executive OfficerOct 14, 2026
Sale
$49.264,098$201.9K259,736
CRSP
Samarth KulkarniDirector, Chief Executive OfficerOct 13, 2026
Option Exercise
—8,333—263,834
CRSP
Samarth KulkarniDirector, Chief Executive OfficerMar 23, 2026
Sale
$46.7810,020$468.7K255,501
CRSP
Samarth KulkarniDirector, Chief Executive OfficerMar 20, 2026
Option Exercise
—19,687—265,521
CRSP
Samarth KulkarniDirector, Chief Executive OfficerMar 16, 2026
Sale
$48.2610,349$499.4K245,834
CRSP
Samarth KulkarniDirector, Chief Executive OfficerMar 14, 2026
Option Exercise
—20,625—256,183
CRSP
Samarth KulkarniDirector, Chief Executive OfficerMar 11, 2026
Sale
$52.809,798$517.3K235,558
CRSP
Samarth KulkarniDirector, Chief Executive OfficerMar 10, 2026
Option Exercise
—19,250—245,356
CRSP
Samarth KulkarniDirector, Chief Executive OfficerFeb 19, 2026
Sale
$52.586,967$366.3K226,106
CRSP
Samarth KulkarniDirector, Chief Executive OfficerFeb 18, 2026
Option Exercise
—13,250—233,073
CRSP
Samarth KulkarniDirector, Chief Executive OfficerJan 22, 2026
Sale
$60.2360,000$3.6M134,201
CRSP
Samarth KulkarniDirector, Chief Executive OfficerJan 20, 2026
Sale
$51.7530,000$1.6M194,201
CRSP
Samarth Kulkarni—Jan 22, 2026
Proposed Sale
$60.8160,000$3.6M—
CRSP
Samarth Kulkarni—Jan 20, 2026
Proposed Sale
$52.6130,000$1.6M—
CRSP
Samarth Kulkarni—Feb 18, 2025
Proposed Sale
$52.2245,000$2.3M—
CRSP
Dr. Samarth Kulkarni—Nov 11, 2024
Proposed Sale
$54.8675,000$4.1M—